scientific and microscope

Our clinical studies

We are committed to make our Clinical trials Information and Results accessible and transparent while maintaining participants privacy.

 

Clinical studies

This site provides information on both ongoing and completed clinical trials sponsored by Pierre Fabre since 2004. Real-world evidence studies which began after 01 January 2020 are also accessible.

 

Total studies

0

Current studies

0

Oncology

0

Dermatology

0

Rare diseases

0

Others

0
Show more filters
Title Therapeutic area Phase Status Start date (Planned) End date

Phase 2, open-label, single arm, multicenter study of Encorafenib, Binimetinib plus Cetuximab in subjects with previously untreated BRAFV600E -mutant metastatic colorectal cancer

Oncology Phase II Completed June 29, 2020 April 11, 2023

A retrospective non interventional study on first line treatment for patientswWith BRAF V600E mutant metastatic colorectal cancer (mCRC) (CAPSTAN CRC)

Oncology RWE Completed April 12, 2020 December 05, 2021

Encorafenib in combination with Cetuximab in BRAFV600E–Mutated Metastatic Colorectal Cancer: A European pooled analysis of observational studies

Oncology RWE Completed January 01, 2020 October 31, 2024

Phase I/II open label dose escalation and dose expansion study of intravenous infusion of W0101, an antibody-drug conjugate, in patients with advanced or metastatic solid tumors. International, multicenter, open label study.

Oncology Phase I / II Completed November 24, 2017 October 04, 2021

Study of efficacy and safety of V0305 solution in children suffering from Iron Deficiency Anaemia (IDA). Phase 3, multicentre, single arm open-label study

Blood Disorders Phase III Completed June 06, 2016 January 24, 2019

Randomized phase III study comparing vinflunine-gemcitabine and gemcitabine-carboplatin combinations in patients ineligible to cisplatin with advanced or metastatic urothelial carcinoma

Oncology Phase III Early termination February 22, 2016 January 08, 2017

Randomized Phase II study comparing single agent oral vinorelbine administered with two different schedules in patients with Advanced Non Small Cell Lung Cancer unfit for a platinum-based chemotherapy

Oncology Phase II Completed October 26, 2015 October 15, 2018

Assessment of the efficacy of a new formulation of minoxidil (DC120) on hair growth, in a minizone model in androgenetic alopecia in men.

Dermatology Phase II Completed August 21, 2015 April 28, 2016

Randomised Phase II Study comparing, as first-line chemotherapy, single-agent Oral Vinorelbine administered with two different schedules in patients with Advanced Breast Cancer

Oncology Phase II Completed August 03, 2015 September 28, 2020

Efficacy and safety of Hemangiol solution in the treatment of high risk infantile hemangioma. A Multinational single arm study

Dermatology Phase III Completed June 29, 2015 February 21, 2017

Efficacy of DC071 mouthwash (0.2% chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction

dental Phase IV Completed March 30, 2015 June 02, 2016

An intra-individual randomised controlled study to evaluate the efficacy and tolerance of the product RV4421 A BS0042 in association with a moderately potent topical corticosteroid in adults with atopic dermatitis

Dermatology Phase II Completed October 01, 2014 July 09, 2015

Effects of F17464 in acute exacerbation of schizophrenia

Psychiatry Phase II Completed August 20, 2014 November 23, 2016

PERMIXON® 160 mg hard capsule versus placebo in the treatment n the treatment of symptomatic lower urinary tract symptoms due to benign prostatic hyperplasia

Urology Phase IV Completed May 07, 2014 June 27, 2016

Phase I-II study of F17752 in patients with advanced solid tumors

Oncology Phase I / II Early termination October 01, 2013 October 13, 2013

Bronchodilator properties and safety of a repeated dose of V0162 inhalation powder in asthma

Respiratory Phase II Completed September 26, 2013 April 30, 2014

Clinical efficacy and safety of J022X ST in the prevention of Recurrent Upper-Respiratory Tract Infections (RURTI) in children with a high risk of recurrence

Respiratory Phase III Completed September 02, 2013 October 17, 2016

Phase III study of Vinflunine plus Capecitabine versus Capecitabine alone in patients with advanced breast cancer

Oncology Phase III Completed September 2013 July 2017

Efficacy and safety study of F373280 for maintenance of sinus rhythm after electrical cardioversion in patients with persistent Atrial Fibrillation and Chronic Heart Failure

Cardiovascular Phase II Completed May 20, 2013 June 21, 2017

Phase I-II study of F14512 in combination with cytarabine in patients 60 years old and older with acute myeloid leukemia

Oncology Phase I / II Early termination April 09, 2013 March 03, 2017

Get access to Partner's pivotal studies supporting our authorized drugs in Europe

Results from pivotal studies conducted by our partners and supporting a marketing approval for whom Pierre Fabre is the holder in Europe are shared below:

 

Melanoma

SPONSOR: PFIZER

Breast cancer 

SPONSOR: PUMA BIOTECHNOLOGY

Colorectal cancer

SPONSOR: PFIZER

Post-transplantation lymphoproliferative disease EBV+

SPONSOR: ATARA